ISRCTN15151491Active, not recruiting未知
Biomarker improvement and development in non-endoscopic samples within the Cyted diagnostic pathway
Cyted Ltd0 sites10,000 target enrollmentStarted: January 31, 2023Last updated:
Trial Snapshot
- Phase
- 未知
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 10,000
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Patient aged 18 and over
- •2. Male or female
- •3. Final pathology report submitted a minimum of 3 months prior to search
Exclusion Criteria
- •1. Samples submitted less than 3 months prior search
- •2. Samples that have not yet resulted in a pathology report
Investigators
Similar Trials
Recruiting
Not Applicable
Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1)Steinerts disease10029299DM1NL-OMON50021Radboud Universitair Medisch Centrum20
Active, not recruiting
Not Applicable
Probiotics and its effect on stress and sleepCTRI/2018/03/012276RGUHS bengaluru
Completed
Not Applicable
Can biomarkers be used to improve patient selection and overall survival in patients starting immunotherapy treatment for non-small cell lung cancer (NSCLC) and genitourinary cancersBladder canceron-small cell lung cancerKidney CancerCancer - Lung - Non small cellCancer - BladderCancer - KidneyNon-small cell lung cancerACTRN12620000090910Ingham Institute for Applied Medical Research48
Completed
Not Applicable
The psychological health benefits of mindfulness-based stress reduction in family caregivers of patients with dementiaSelf-perceived stress, depression, burden and grief in non-professional caregivers of dementia patientsMental and Behavioural DisordersISRCTN53169488Icahn School of Medicine at Mount Sinai (USA)20
Recruiting
Not Applicable
Development of surrogate end-point biomarkers for chronic fatigue and myalgic encephalmyelitis/chronic fatigue syndrome ( ME/CFS)JPRN-UMIN000029076Osaka City University120